RxDoctor Payments Data

Karen Snyder, PA

Physician Assistant · Williamsport, PANPI 1598724809

Payments from drug & device makers

$616in general payments, 2019–2025

Across 25 payments — averaging $24.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$330
  • Bayer$125
  • Alkermes, Inc.$45
  • Novartis$32
  • Pfizer$28
  • Biohaven Pharmaceutical Holding Company Ltd.$28
  • plus $28 from 2 others

What the payments were for

  • Food & beverage$616100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$616 in reported general payments places this provider in the 70th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$25,052
Medicare patients
46
Services billed
414

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$23,762
JardianceEmpagliflozin29$21,396
OzempicSemaglutide20$21,160
EliquisApixaban27$19,503
TrulicityDulaglutide18$18,986
Breo ElliptaFluticasone/Vilanterol23$9,454
TradjentaLinagliptin11$8,725
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$3,354
Rosuvastatin Calcium132$1,102
Diltiazem 12hr ErDiltiazem Hcl12$1,094
SynthroidLevothyroxine Sodium12$1,055
Albuterol Sulfate HfaAlbuterol Sulfate24$927
Omeprazole80$839
Pregabalin13$798
Levothyroxine Sodium110$789

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$28$19,50327 claims
AbbVieSynthroid$330$1,05512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Williamsport

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →